Evergy, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Evergy, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,562	2,571	4,276	5,148	4,913	5,587	5,859	5,508	5,847	5,962
Operating income	702	679	934	1,186	1,144	1,355	1,267	1,282	1,468	1,533
Interest expense	162	171	280	374	384	373	404	526	563	616
Other non-operating income	-1.5	-26.8	-54.4	-39	-36.1	18.8	-58	-4.8	3.1	-25.6
Pre-tax income	539	481	600	773	724	1,001	805	752	908	891
Income tax	185	151	59	97	102	117	47.5	15.6	30	29.9
Net income to minority interests	14.6	12.6	10.2	15.7	11.7	12.2	12.3	12.3	12.3	12.3
Net income	347	324	536	670	618	880	753	731	874	856
EBITDA	1,041	1,051	1,552	2,048	2,024	2,251	2,197	2,359	2,582	2,696
EPS, basic	2.43	2.27	2.50	2.80	2.72	3.84	3.27	3.18	3.79	3.71
EPS, diluted	2.43	2.27	2.50	2.79	2.72	3.83	3.27	3.17	3.79	3.66
Shares, basic (weighted)	142	143	214	240	227	229	230	230	230	231
Shares, diluted (weighted)	143	143	214	240	228	230	230	231	231	234
Dividend per share	1.52	1.60	1.74	1.93	2.05	2.18	2.33	2.48	2.60	2.70

Balance sheet

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	3.2	3.4	160	23.2	145	26.2	25.2	27.7	22	19.8
Receivables		291	194	229	274	222	315	257	245	214
Other current assets		39.8	79.1	78.2	23.7	75.4	44.5	31.4	45.4	47.4
Total current assets		727	1,681	1,468	1,624	1,710	1,842	1,789	1,839	1,816
Property, plant and equipment		9,554	18,783	19,184	19,951	21,003	22,137	23,729	24,931	26,302
Lease right-of-use assets				105	93.2		77.4	71.1	58.3	62
Goodwill		0	2,339	2,337	2,337	2,337	2,337	2,337	2,337	2,337
Other non-current assets		245	397	512	528	563	535	560	576	593
Total assets		11,624	25,598	25,976	27,115	28,521	29,490	30,976	32,282	33,949
Accounts payable		204	452	529	654	640	601	617	614	654
Accrued liabilities				59.2	55.5	51.6	81.1	74.5	73
Short-term debt		0	705	251	436	389	439	800	652	367
Total current liabilities		824	2,867	2,336	2,356	3,103	3,494	3,513	3,662	3,696
Long-term debt		3,688	6,636	8,747	9,191	9,298	9,906	11,053	11,809	13,039
Lease liabilities				82.4			60	53.3	43.1	44.6
Other non-current liabilities		133	237	341	308	310	288	288	311	358
Total liabilities		7,764	15,607	17,431	18,396	19,279	19,997	21,291	22,293	23,681
Total debt		3,688	7,342	8,998	9,627	9,687	10,345	11,853	12,461	13,406
Retained earnings		1,173	1,346	1,552	1,703	2,083	2,299	2,458	2,733	2,966
Other comprehensive income		0	-3	-50	-49.4	-44	-34.5	-29.6	-23.8	-18
Shareholders' equity		3,908	10,028	8,572	8,733	9,244	9,484	9,663	9,955	10,221
Minority interests		-47.7	-37.5	-26.6	-14.9	-2.7	9.6	21.9	34.2	46.5
Total equity	3,833	3,860	9,991	8,545	8,719	9,242	9,493	9,685	9,989	10,268
Total liabilities and equity		11,624	25,598	25,976	27,115	28,521	29,490	30,976	32,282	33,949

Cash flow statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	361	337	546	686	630	892	765	744	886	868
Depreciation and amortization	339	372	619	862	880	896	929	1,077	1,114	1,163
Stock-based compensation	9.3	8.8	29.9	16.3	16	15.6	18.8	17.7	15.2	20.7
Deferred income tax	188	154	128	121	133	108	13.8	-11.5	-1.4	27.9
Change in receivables	-30.3	-2.1	265	-23.1	-4.9	69.9	-59.8	54.5	16.7	19.9
Change in payables	-8.1	10	56.7	16.9	134	-55.1	2.1	-47.2	46	-6.8
Cash from operations	804	913	1,498	1,749	1,754	1,352	1,802	1,980	1,984	2,045
Capital expenditures	-1,087	-765	-1,070	-1,210	-1,560	-1,973	-2,167	-2,334	-2,337	-2,797
Cash from investing	-994	-781	197	-1,080	-1,534	-1,914	-2,152	-2,472	-2,262	-2,570
Debt issued	396	296	291	2,373	889	497	568	2,445	1,414	1,688
Debt repaid	-50	-125	-396	-701	-251	-432	-411	-440	-812	-751
Stock issued				0	0	113	0	0	0	1.1
Share buybacks	0	0	-1,042	-1,629	0	0
Dividends paid	-204	-223	-475	-463	-465	-498	-535	-570	-597	-613
Cash from financing	190	-132	-1,538	-806	-98.4	443	349	494	280	522
Net change in cash	-0.1	0.3	157	-137	122	-119	-1	2.5	2.2	-2.9
Free cash flow	-283	148	428	539	194	-621	-365	-354	-353	-752
Interest paid	139	154	256	330	368	357	394	501	539	587
Income taxes paid	13.1	-12.7	-0.9	-5.2	-46.5	-19.6	21.6	34.4	38	6.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $78.04 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	25.9%	Operating income / revenue.
EBITDA margin	45.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	15.1%	Pre-tax income / revenue.
Net margin	14.6%	Net income / revenue.
FCF margin	-18.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	32.5%	Cash from operations / revenue.
Effective tax rate	2.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.6%	Net income / average total assets.
Return on invested capital (ROIC)	6.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	50.7%	Capital expenditures / revenue.
D&A / revenue	19.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	2.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	4.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	6.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	4.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	7.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	5.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-2.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	4.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	6.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-3.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	3.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	6.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	3.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	3.9%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	5.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	5.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	2.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	3.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	5.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	4.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.45x	Current assets / current liabilities.
Quick ratio	0.05x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.00x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.33x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	39.2%	Total debt / total assets.
Liabilities / assets	70.4%	Total liabilities / total assets.
Net debt	$13.50B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.93x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.44x	Operating income / interest expense.
Working capital	-$2.34B	Current assets - current liabilities.
Goodwill and intangibles / assets	6.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$7.82B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.17x	Revenue / average total assets.
Fixed asset turnover	0.22x	Revenue / average property, plant and equipment.
Receivables turnover	30.0x	Revenue / average receivables.
Days sales outstanding	12 days	365 x average receivables / revenue.
FCF conversion	-124.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	156.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.74	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$25.60	Revenue / diluted weighted shares.
FCF per share	-$4.66	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.31	Cash from operations / diluted weighted shares.
Book value per share	$43.11	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$33.19	Tangible book value / shares outstanding.
Cash per share	$0.08	(Cash + short-term investments) / shares outstanding.
Payout ratio	70.0%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$17.99B	Share price x shares outstanding.
Enterprise value	$31.49B	Market cap + total debt - cash - short-term investments.
P/E	20.4x	Market cap / net income. Only when net income is positive.
P/S	2.98x	Market cap / revenue.
P/B	1.77x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.30x	Market cap / tangible book value, when positive.
P/OCF	9.19x	Market cap / cash from operations, when positive.
EV/Sales	5.22x	Enterprise value / revenue.
EV/EBIT	20.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.5x	Enterprise value / EBITDA, when both are positive.
FCF yield	-6.1%	Free cash flow / market cap.
Earnings yield	4.9%	Net income / market cap (the inverse of P/E).
Dividend yield	3.4%	Dividends paid over the period / market cap.
Shareholder yield	3.4%	(Dividends paid + share buybacks) / market cap.
PEG	5.33x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Evergy, Inc.'s revenue in fiscal 2025?

Evergy, Inc. reported revenue of $5.96B for fiscal 2025, 2% higher than the year before.

Was Evergy, Inc. profitable in fiscal 2025?

Yes. Net income was $855.6M, a net margin of 14.4%.

How much free cash flow did Evergy, Inc. generate in fiscal 2025?

Cash from operations of $2.05B minus capital expenditures of $2.80B left free cash flow of -$751.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Evergy, Inc.